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Background: Peripheral arterial disease (PAD) of the lower limbs is a cardiovascular disease highly prevalent
particularly in the asymptomatic form. Its prevalence starts to be a concern in low coronary risk countries like Spain.
Few studies have analyzed the relationship between ankle-brachial index (ABI) and cardiovascular morbi-mortality in
low cardiovascular risk countries like Spain where we observe significant low incidence of ischemic heart diseases
together with high prevalence of cardiovascular risk factors. The objective of this study is to determine the
relationship between pathological ABI and incidence of cardiovascular events (coronary disease, cerebrovascular
disease, symptomatic aneurism of abdominal aorta, vascular surgery) and death in the >49 year population-based
cohort in Spain (ARTPER).
Methods: Baseline ABI was measured in 3,786 randomly selected patients from 28 Primary Health Centers in
Barcelona, distributed as: ABI<0.9 peripheral arterial disease (PAD), ABI ≥1.4 arterial calcification (AC), ABI 0.9-1.4
healthy; and followed during 4 years.
Results: 3,307 subjects were included after excluding those with previous vascular events. Subjects with abnormal
ABI were older with higher proportion of men, smokers and diabetics. 260 people presented cardiovascular events
(incidence 2,117/100,000 person-years) and 124 died from any cause (incidence 978/100,000 person-years). PAD had
two-fold greater risk of coronary disease (adjusted hazard ratio (HR) = 2.0, 95% confidence interval (CI) 1.3-3.2) and
increased risk of vascular surgery (HR = 5.6, 95%CI 2.8-11.5) and mortality (HR = 1.8, 95%CI 1.4-2.5). AC increased
twice risk of cerebrovascular events (HR = 1.9, 95%CI 1.0-3.5) with no relationship with ischemic heart disease.
Conclusions: PAD increases coronary disease risk and AC cerebrovascular disease risk in low cardiovascular risk
Mediterranean population. ABI could be a useful tool to detect patients at risk in Primary Health Care.
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Cohort studiesBackground
Prevention and early diagnosis of arteriosclerotic disease
is one of the essential objectives in the field of cardiovas-
cular disease since it is the main cause of mortality in
developed countries. In Spain, cardiovascular diseases* Correspondence: maiteal2007@gmail.com
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Ischemic heart disease causes the greatest number of
cardiovascular deaths (29%) followed by cerebrovascular
disease (25%) [1].
Peripheral arterial disease (PAD) of the lower limbs is
a cardiovascular disease highly prevalent particularly in
the asymptomatic form. Its prevalence starts to be a
concern in low coronary risk countries like Spain. Three
different groups have studied it using the ankle-brachial
index (ABI) with similar methodology. They have found
PAD prevalence between 3.7% and 7.6% [2-5].al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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main undiagnosed even with the presence of intermit-
tent claudication symptoms [6]. On the other hand
arterial calcification (AC), defined as ABI ≥1.4, has a
prevalence of 6.2% in our country in the population >
49 years of age [7].
PAD is associated to high cardiovascular risk, in both
symptomatic and asymptomatic forms. Several studies
have found high incidence of cardiovascular events and
mortality in patients with PAD. The MESA Study, car-
ried out in the USA, observed a hazard ratio (HR) 1.8 to
develop cardiovascular morbi-mortality in patients with
PAD [8]. Ankle Brachial Index Collaboration metanalysis
showed that patients with PAD had in ten years between
2 and 4 times higher risk to die or to present major car-
diovascular events than patients with no PAD [9].
Although the relationship between AC and morbi-
mortality has been less studied it seems to have a positive
association. Ankle Brachial Index Collaboration metanaly-
sis [9] found a moderate association with HR between 0.9
and 1.5 whereas the MESA Study observed HR 1.8 to suf-
fer a cardiovascular event or dead in patients with AC
compared with healthy patients [8].
Few studies have analyzed the relationship between
ABI and cardiovascular morbi-mortality in low cardio-
vascular risk countries like Spain where we observe
significant low incidence of ischemic heart diseases to-
gether with high prevalence of cardiovascular risk factors
[10-12]. Carbayo et al. obtained HR 1.7 for cardiovascu-
lar events or death in patients with PAD with no history
of previous episodes [13]. Moreover, Merino et al.
showed that PAD increased the risk to suffer a major
coronary episode only including men in the study re-
gardless of previous events [14].
The objective of this study is to determine the rela-
tionship between pathological ABI and incidence of car-
diovascular events (coronary disease, cerebrovascular
disease, symptomatic aneurism of abdominal aorta,
vascular surgery) and death in the > 49 year population-
based cohort in Spain (ARTPER) [7]. Once it is con-
firmed an association of PAD and/or AC to increased
incidence of cardiovascular events in a low cardiovascu-
lar risk country as Spain then ABI can be recommended
as a simple, fast and inexpensive tool in the Primary
Health Care setting to detect patients at risk.
Methods
The ARTPER Study is an ongoing prospective obser-
vational population-based cohort study initiated in
October 2006. A detailed description of the method-
ology of the study has been published elsewhere [15].
Briefly, at baseline ABI was measured in 3,786 ran-
domly selected patients over the age of 49 years regis-
tered in 28 Primary Health Care centers of Barcelonaregion from a database including the population ascribed
in the participating centers, which is even more exhaust-
ive and updated than the census. All the subjects entered
in one of the following cohorts: ABI < 0.9 peripheral
arterial disease, ABI ≥ 1.4 arterial calcification, ABI be-
tween 0.9 and 1.4 healthy. An average of 4-year follow
up was carried out, with phone contacts undertaken
every 6 months from baseline to August 2012.
End points
The appearance of any of the events: myocardial infarc-
tion, angina, stroke, transient ischemic attack, symptom-
atic aneurysm of abdominal aorta, vascular surgery
(coronary, intracranial and extracranial); and vascular
and overall mortality were recorded through electronic
medical records, computerized clinical history, telephone
interviews with the subject or with a relative, personal or
telephone interview with the general practitioner in
charge of the patient, the emergency departments and
emergency paramedical services, and the mortality stat-
istical records. Finally, all the events have been checked
by a medical committee whose members perform rou-
tine clinical practice.
Incidence events have been grouped as follows: coron-
ary disease (acute myocardial infarction or angina), cere-
brovascular disease (stroke or transient ischemic attack),
symptomatic aneurysm of the abdominal aorta (SAAA),
vascular surgery, cardiovascular morbidity (any of the
4 previous ones), mortality (vascular or non-vascular
cause), overall mortality and morbid-mortality (any of
the mentioned events). It was only taken into account
the first episode for each type of event. Any patient that
had an event at the time of recruiting or a history of an
event was excluded from the analysis.
Statistical analysis
PAD and AC patient baseline profiles were separately
compared to healthy patients using Chi-square test. Inci-
dence was calculated as the number of observed events
per 100,000 person-year (py), calculating Poisson 95%
confidence interval (CI). Incidence of every event was
associated to each of the three cohorts by means of Cox
proportional hazard models, “healthy” was the reference
category. Univariate associations were investigated first,
and then multivariable models were carried out, adjust-
ing by age, gender, smoking (ever = current + former),
abdominal and general obesity, hypertension, hyperchol-
esterolemia and diabetes, calculating HR and 95% CI.
For each event of the study, likelihood ratio tests were
used to assess the interaction of PAD (or AC) with
the adjusting variables listed above. Age, abdominal
and general obesity were used as continuous in Cox
and interaction models. Kaplan-Meier survival function
curves were done, comparing survival rates per event
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0.05 was considered statistically significant. Statistical
analysis was performed with Stata 12.1 (StataCorp LP)
software.
Ethics
This study was approved by the local Ethics Committee
(IDIAP Jordi Gol Foundation of Investigation in Primary
Care and Instituto de Salud Carlos III).
Informed written consent was obtained from all the
participants. Likewise, the recommendations of the
World Medical Association Declaration of Helsinki were
followed.
Results
At baseline (2006–2008) 3,786 >49 year old people
were enrolled representing 63% participation. BaselineTable 1 Baseline variables by ankle-brachial index (ABI)
Healthy
ABI 0.9-1.4 n = 2916 ABI <
n % n
Gender
Men 1214 41.6% 105
Women 1702 58.4% 88
Age at recruitment
49-60 1116 38.3% 38
60-70 1084 37.2% 52
70-97 716 24.6% 103
General obesity
Underwheight/Average (BMI** < 25 Kg/m2) 516 17.7% 43
Overweight (BMI 25–29.9 Kg/m2) 1337 45.9% 75
Obese (BMI≥ 30 Kg/m2) 1059 36.4% 75
Abdominal obesity (waist circumference)‡
<102 cm men / <88 cm women 1144 39.5% 71
≥102 cm men / ≥88 cm women 1749 60.5% 122
Smoking
Never smoked 1712 58.7% 82
Ever smoked 1204 41.3% 111
Co-morbidity (medical records)
Hypertension§ 1205 41.9% 122
Hypercholesterolemia_ 1283 45.0% 106
Diabetes 380 13.0% 55
ABI: ankle-brachial index, PAD: peripheral arterial disease, AC: arterial calcification.
Individuals with prevalent events excluded.
*: p-value comparing ABI < 0.9 with ABI 0.9-1.4.
†: p-value comparing ABI ≥ 1.4 with ABI 0.9-1.4.
All comparisons made with chi-squared test.
**: BMI: body mass index.
‡ 0, 23 and 2 missing values among each ABI group.
§ 3, 41 and 7 missing values among each ABI group.
_ 3, 67 and 3 missing values among each ABI group.prevalence of PAD and AC was 7.6% and 6.2% respect-
ively [4]. 479 members of the ARTPER cohort previously
presented some cardiovascular event and therefore were
excluded from the analysis of the study. 3,307 people
were enrolled to follow up, 193 (5.8%) had PAD and 198
(6.0%) AC. Demographics of the study population are
shown in Table 1. 44% were men. Mean age at enrol-
ment was 64.2 years (standard deviation (SD) 8.7, range
49–97). Patients with PAD or AC were older (6 and
2 years respectively) with higher proportion of men,
smokers, hypertensive and diabetics. Patients with AC
were more likely to be obese and patients with PAD
more likely to present hypercholesterolemia.
3,307 subjects were followed up during an average of
3.83 years (SD 0.73, range 59 days- 5.56 years, median
4.03 years) adding up 12,677 person-years. 260 partici-
pants presented cardiovascular events (incidence 2,117/PAD AC
0.9 n = 193 ABI ≥ 1.4 n = 198 Total n = 3307
% N % n % p* p†
0.001 <0.001
54.4% 125 63.1% 1444 43.7%
45.6% 73 36.9% 1863 56.3%
<0.001 0.003
19.7% 59 29.8% 1213 36.7%
26.9% 70 35.4% 1206 36.5%
53.4% 69 34.8% 888 26.9%
0.112 <0.001
22.3% 13 6.6% 572 17.3%
38.9% 86 43.4% 1498 45.4%
38.9% 99 50.0% 1233 37.3%
0.448 0.040
36.8% 63 32.1% 1278 38.9%
63.2% 133 67.9% 2004 61.1%
<0.001 0.007
42.5% 97 49.0% 1891 57.2%
57.5% 101 51.0% 1416 42.8%
64.2% 101 52.9% 1428 43.9% <0.001 0.003
55.8% 95 48.7% 1484 45.9% 0.004 0.317
28.5% 48 24.2% 483 14.6% <0.001 <0.001
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cerebrovascular disease, 19 SAAA and 45 vascular sur-
gery. 124 patients died from any cause (incidence 978/
100,000 py), 29 of them from vascular disease. A total of
347 patients suffered one cardiovascular event and/or
died (Table 2). Kaplan-Meier survival curves are shown
in Figure 1, being significant worse for PAD in coronary
disease, cardiovascular morbidity and mortality and for
AC in cerebrovascular disease.
PAD increased two- fold the risk of coronary disease
(HR = 2.0, 95% CI 1.3-3.2) and also increased the risk of
vascular surgery (HR = 5.6, 95% CI 2.8-11.5), cardiovascu-
lar morbidity (HR = 2.1, 95% CI 1.5-2.9) and morbi-
mortality (HR = 1.8, 95% CI 1.4-2.5) irrespective of other
cardiovascular risk factors. Although not statistically sig-
nificant PAD also increased the risk to suffer SAAA and
vascular mortality. AC increased twice the risk to present
cerebrovascular events (HR = 1.9, 95% CI 1.0-3.5) with no
relationship with ischemic heart disease (Table 2).
It was observed that the effect of PAD on coronary
disease was higher in men, in younger, but lower in ab-
dominal obese, in smokers, in non-hypertensives and in
diabetics. When applying interaction test this effect was
only statistically significant for hypertension (Figure 2).
This pattern was maintained linking PAD with cardio-
vascular morbidity, now with lower effects for higher
body mass index. It was statistically significant the inter-
action of PAD with gender, hypertension and general
and abdominal obese. On the other hand, PAD had a
similar effect in cerebrovascular disease for each level of
cardiovascular risk factors analyzed, as occurred with
overall mortality (these data is not shown).
Higher effect was observed for AC regarding cerebro-
vascular disease in smokers, hypertensives, diabetics and
abdominal (but not general) obese. However in no case
the interaction of AC with these risk factors was statisti-
cally significant (Figure 3). AC had the same effect over
coronary disease, cardiovascular morbidity and mortality
across the different levels of the cardiovascular risk fac-
tors (data not shown).
High proportion of PAD patients (70%) presented
asymptomatic PAD (133 patients). 56 patients (30%) pre-
sented intermittent claudication. 4 had no information.
The interaction between PAD and intermittent claudica-
tion was not statistically significant to any of the studied
events. However, the greatest difference of the PAD ef-
fect was found for cardiovascular morbidity. Compared
to healthy, those with intermittent claudication had
HR = 2.6, 95% CI 1.6-4.2, and those with asymptomatic
PAD had HR = 1.7, CI 95% 1.1-2.7.
Discussion
In the low cardiovascular risk cohort ARPER it is con-
firmed the importance of ABI <0.9 as an independentrisk factor to have coronary disease, cardiovascular mor-
bidity and mortality. Meanwhile ABI ≥ 1.4 is an inde-
pendent risk factor to present a cerebrovascular disease.
In Spain there are no prospective studies that analyze
at the same time PAD and AC as predictors of vascular
events. The Albacete general population cohort [13] and
the Barcelona men cohort [14] only analyzed PAD. They
found similar results to our study: HR 1.9 for overall
mortality and HR 3.0 for coronary disease respectively.
Our study found that patients with PAD had two-fold
the risk to present a coronary event, similar results were
obtained in the MESA Study (HR 1.9) [8] and in the 16
cohort ABI Collaboration metanalysis [9], (adjusted HR
2.2 for men and 2.5 for women, defining healthy as those
with ABI between 1.11 and 1.40 ).
In our cohort, patients with PAD increased two- fold
the risk of cardiovascular morbidity, morbi-mortality
and mortality. For mortality, the higher effect was found
in vascular mortality, without reaching statistical signifi-
cance. ABI Collaboration metanalysis found an adjusted
HR of PAD on the overall mortality 2.3 in men and 2.4
in women and greater than 3 for cardiovascular mortal-
ity [9]. The getABI Study, performed in Primary Health
Care setting like the ARTPER study, obtained adjusted
HR 2.0 for mortality and 1.9 for morbi-mortality in >
65 year old cohort [16].
We did not observe any link between PAD and cere-
brovascular disease. Same results were found in the
MESA (HR 1.6) [8], ARIC (HR 1.9) [17] and Cardiovas-
cular Health Study (adjusted HR 1.1) [18], although
these results were not statistically significant. However,
other studies like the German Cohort getABI [19] and
the 6-study metanalysis of Heald et al. [20] observed that
PAD incremented the risk to suffer cerebrovascular dis-
ease (HR of 1.8 and 1.4 respectively). Both studies re-
cruited older patients than ARTPER. In the Heald
metanalysis, the studies that found statistically significant
effect of PAD on stroke were the ones that enrolled >
70 year old patients.
We found association between PAD and vascular sur-
gery and SAAA, the last with no statistical significance.
These associations together to the effect observed on the
coronary disease could explain the increased incidence
of cardiovascular morbidity in patients with PAD. Al-
though few studies have researched the association of
PAD with vascular surgery or SAAA, their results are
comparable to ours, like the getABI Study (adjusted HR
1.6 for coronary-artery revascularization in patients with
PAD) [21].
With regards to AC we found an association between
AC and cerebrovascular disease but not with other car-
diovascular diseases or mortality. Likewise the MESA
Study found greater effect of AC on stroke (HR 2.7) than
on coronary disease (HR 2.2) [8]. ABI Collaboration
Table 2 Incidence of cardiovascular events among different ankle-brachial index groups
Total n = 3307 ABI 0.9-1.4 n = 2916 ABI < 0.9 n = 193 ABI ≥ 1.4 n = 198
n I CI95% n I CI95% n I CI95% HR CI95% p n I CI95% HR CI95% p
Coronary disease 140 1124 946 1327 105 953 780 1154 27 3808 2510 5541 2.0 1.3 3.2 0.003 8 1100 475 2168 0.8 0.4 1.6 0.522
Cerebrovascular disease 107 853 699 1031 80 723 573 899 14 1895 1036 3180 1.2 0.7 2.3 0.505 13 1783 949 3049 1.9 1.0 3.5 0.051
SAAA* 19 150 90 235 14 125 69 211 4 537 146 1374 3.1 0.9 9.9 0.063 1 135 3 754 0.8 0.1 6.4 0.857
Vascular surgery 45 357 260 478 29 260 174 374 14 1941 1061 3257 5.6 2.8 11.5 <0.001 2 271 33 978 0.9 0.2 3.6 0.831
Cardiovascular morbidity 260 2117 1868 2391 191 1754 1514 2021 48 7104 5238 9418 2.1 1.5 2.9 <0.001 21 2935 1817 4487 1.2 0.7 1.9 0.474
Mortality 124 978 814 1166 95 849 687 1038 20 2657 1623 4104 1.5 0.9 2.4 0.141 9 1216 556 2308 1.0 0.5 2.0 0.947
Vascular 29 229 153 329 19 170 102 265 8 1063 459 2094 2.4 1.0 6.0 0.060 2 270 33 976 1.2 0.3 5.1 0.847
Non vascular 95 749 606 916 76 680 535 851 12 1594 824 2785 1.2 0.6 2.2 0.598 7 945 380 1948 1.0 0.5 2.2 0.947
Morbi-mortality 347 2826 2536 3139 263 2415 2132 2726 59 8731 6647 11263 1.8 1.4 2.5 <0.001 25 3495 3495 5159 1.0 0.7 1.6 0.838
ABI: ankle-brachial index, PAD: peripheral arterial disease, AC: arterial calcification.
*: SAAA: symptomatic aneurysm of the abdominal aorta.
Individuals with prevalent events excluded.
I = incidence per 100,000 person-year.
CI95% = 95% confidence interval of incidence (Poisson distribution) or of hazard ratio (Cox model).
HR = adjusted hazard ratio (reference ABI 0.9-1.4). HR are based on 2,799 healthy, 187 peripheral arterial disease and 189 arterial calcification subjects.
HR are adjusted by age, gender, smoking, central and general obesity, hypertension, hypercholesterolemia and diabetes.
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Figure 1 Kaplan-Meier survival curves for coronary and cerebrovascular diseases, cardiovascular morbidity and mortality among
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Figure 2 Effect of peripheral arterial disease for coronary disease, measured by hazard ratio (HR), among different potential
cardiovascular risk factors.
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Figure 3 Effect of arterial calcification for cerebrovascular disease, measured by hazard ratio (HR), among different potential
cardiovascular risk factors.
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(HR 1.3) [9], but not with coronary diseases. Whereas
Sutton-Tyrrell found a relationship with coronary heart
disease (HR 1.5) but not with stroke or mortality in an
American cohort of >70 year old, with AC ABI cut-off
of >1.3 [22].
The effect of PAD was not homogeneous among the
cardiovascular risk factors. PAD seems to have greater
effect on coronary disease in men, in <70 year old
patients, in overweight with no abdominal obesity,
smokers, diabetes, non-hypertension and dyslipidemia. It
was only statistically significant the interaction of PAD
with hypertension. We obtained comparable results with
PAD and cardiovascular morbidity being statistically sig-
nificant the interaction with gender, age and hyperten-
sion. There is scarce information in the literature about
this. In our setting it has been studied the effect of PAD
on cardiovascular morbidity in diabetics with similar re-
sults (HR 2.3) [23]. Nevertheless Hansen et al. did not
find any difference of the effect of PAD on mortality be-
tween diabetics and non-diabetics [24].
70% of the patients with PAD were asymptomatic.
This may delay the diagnosis of the disease and therefore
have the risk to suffer a cardiovascular event in the fu-
ture. However, similarly to the getABI Study [21], we ob-
tained few differences of vascular events in patients with
symptomatic PAD and asymptomatic PAD.
As described by other authors, the presence of PAD
cannot be excluded in patients with AC because the ar-
terial stiffness impedes a proper ABI measurement.
Therefore, in our study the detection of patients with
PAD and its effects could be underestimated [25,26]. Inspite of that, both PAD and AC have shown an increase
of cardiovascular risk and should be properly taken into
account.
Patients with previous history of cardiovascular events
were excluded from the study because they received sec-
ondary prevention treatment. Although these patients
are at higher risk to get sick or to die [27] we preferred
to concentrate our results in subjects to whom a primary
prevention intervention should be done.
When patients with PAD were recruited we had to
start secondary prevention treatment and therefore the
effect of PAD on the cardiovascular events could be
underestimated. Moreover, subjects may have changed
their habits during the follow up period and prompted
some misclassification attached to all longitudinal stud-
ies. These changes could be analyzed in future evalua-
tions of the ARTPER cohort.
Our data is based on a 4 years follow-up, a period that
could be too short to find significant associations be-
tween PAD and some of our cardiovascular outcomes or
the interaction with other cardiovascular risk factors.
However, despite our short follow-up we find relation-
ship between PAD and coronary disease, vascular sur-
gery, cardiovascular morbidity and morbi-mortality and
between AC and cerebrovascular events, with significant
interactions of PAD with gender, age and hypertension
for cardiovascular morbidity.
Conclusions
In conclusion, in the low cardiovascular risk cohort
ARTPER it is confirmed the importance of PAD as an
independent risk factor to present coronary disease,
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dependent risk factor to present cerebrovascular disease.
The presence or absence of risk factors can modify the
effect of PAD on cardiovascular diseases and this should
be further studied in the future. The measurement of
PAD and AC in the Primary Health Care consultation
may detect high cardiovascular risk patients. Even
though ABI is a simple and inexpensive instrument it
will be important to define the profile of patients that
are candidates to have abnormal ABI in order to have a
more cost-effective screening tool.
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